Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| ODTX |
| Odyssey Therapeutics, Inc. |
| CCONV◆ |
| 20,000 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 11,083 | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV◆ | 18,531 | — | — | — | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | FTAX | 4 | $18.00 | $72 | <0.1% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | MEXER | 541 | — | — | +7.8% | Open the original filing on SEC.gov |
| May 11 | ODTX | Odyssey Therapeutics, Inc. | CCONV | 6,965 | — | — | — | Open the original filing on SEC.gov |
| May 7 | ODTX | Odyssey Therapeutics, Inc. | AGRANT◆ | 27,777 | — | — | — | Open the original filing on SEC.gov |
| May 7 | ODTX | Odyssey Therapeutics, Inc. | AGRANT◆ | 250,203 | — | — | — | Open the original filing on SEC.gov |